Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma.
about
The Nrf2/HO-1 Axis in Cancer Cell Growth and ChemoresistanceIdentification of a functional antioxidant response element within the eighth intron of the human ABCC3 geneCytoprotection "gone astray": Nrf2 and its role in cancerAberrant regulation of the MRP3 gene in non-small cell lung carcinomaProtein carbonylation and metabolic control systems.The involvement of NRF2 in lung cancerLOSS of Mrp1 alters detoxification enzyme expression in a tissue- and hormonal-status-specific manner.Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells.Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitinationWogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation.The cytoprotective role of the Keap1-Nrf2 pathway.Nrf2: control of sensitivity to carcinogens.Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.Redox signaling: An evolution from free radicals to agingNrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.Expression of UDP-glucuronosyltransferase 1A, nuclear factor erythroid-E2-related factor 2 and Kelch-like ECH-associated protein 1 in colonic mucosa, adenoma and adenocarcinoma tissue.Oxidative stress and lipid peroxidation products in cancer progression and therapy.Positron emission tomography-computed tomography and 4-hydroxynonenal-histidine immunohistochemistry reveal differential onset of lipid peroxidation in primary lung cancer and in pulmonary metastasis of remote malignancies.The subcellular localization and activity of cortactin is regulated by acetylation and interaction with Keap1.Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response.Camptothecin suppresses NRF2-ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs.Selective ATP-Binding Cassette Subfamily C Gene Expression and Proinflammatory Mediators Released by BEAS-2B after PM2.5, Budesonide, and Cotreated Exposures.Importance of the Keap1-Nrf2 pathway in NSCLC: Is it a possible biomarker?
P2860
Q26772298-2519816F-FF08-4A27-A7AD-4EE172B187E6Q28250453-DA7F57A5-70F1-4C71-95C1-80645C2D5F7DQ28393784-0EC3733E-BDBD-479C-98A6-F6FA54B3EB96Q35621694-7B24B79D-61D0-4640-9BAE-F23C964479A1Q36129390-8B0D9F21-6162-4868-BB60-9F0FE67C1E08Q36734146-AE70B023-DDA6-4F4B-AAA3-7853A94EE56BQ37058949-030A2846-62F0-4D68-B849-8BE14F1E1450Q37223268-5E23D4BF-8438-4FC2-8AD1-4C593AC2C2A2Q37599046-3FB8274D-9CA6-418B-9BEC-2A3D089AAFB3Q37620581-C03E175B-B509-4899-92CE-02A20020CB39Q37848718-AC0ACC09-F4A0-4F1F-AEA6-4B4E5C788A44Q37849195-40DCCDE4-1C81-4685-A079-F470A086DB01Q38869922-36A68480-DC22-4DC6-B019-99C7DE72B3C4Q38890566-630D210B-C0A8-452C-8742-11C527C107E8Q39490189-A454CCDC-BA03-4EC9-8B2D-0C5198C398FEQ41113863-C0192437-50A1-4EDC-9E6A-842177A36EA7Q41646063-A430C0B5-2E2B-478B-8070-11229C431863Q41876055-F68D3DD0-AC2B-4EC3-A885-7893AF2229C1Q42485470-5BC82ACE-C834-4838-A77A-3D4EB0A05693Q45349809-D67F2F32-D3F6-4B2A-A7C7-F2ADC32154C8Q47802066-E0153526-09EF-41E2-8EDE-7BDD2700E70CQ47813843-C27167D5-A4AF-409D-8FD3-0A25AD0C02BAQ57786820-3A4B3D16-0D5E-479F-942B-06DA71790923
P2860
Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multidrug-resistant protein-3 ...... non-small-cell lung carcinoma.
@en
Multidrug-resistant protein-3 ...... non-small-cell lung carcinoma.
@nl
type
label
Multidrug-resistant protein-3 ...... non-small-cell lung carcinoma.
@en
Multidrug-resistant protein-3 ...... non-small-cell lung carcinoma.
@nl
prefLabel
Multidrug-resistant protein-3 ...... non-small-cell lung carcinoma.
@en
Multidrug-resistant protein-3 ...... non-small-cell lung carcinoma.
@nl
P2093
P2860
P1476
Multidrug-resistant protein-3 ...... non-small-cell lung carcinoma
@en
P2093
Alessandra Rinna
Christopher M Mahaffey
Hongqiao Zhang
Philip C Mack
William Holland
P2860
P304
P356
10.1016/J.FREERADBIOMED.2009.03.023
P577
2009-04-05T00:00:00Z